RxDoctor Payments DataLook up a doctor →

Ansar Khan, MD

Urology · Fremont, NENPI 1093794935

Payments from drug & device makers

$20,763in general payments, 2019–2025

Across 459 payments — averaging $45.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neotract Inc.$8K
  • Coloplast$2K
  • Angiodynamics, Inc.$2K
  • Astellas Pharma US Inc$2K
  • Johnson & Johnson$1K
  • AbbVie$782
  • plus $5K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neotract Inc.12$7,991
Coloplast31$2,181
Angiodynamics, Inc.8$1,856
Astellas Pharma US Inc62$1,551
Johnson & Johnson55$1,155
AbbVie(2 entities)46$782
Sumitomo Pharma America, Inc.61$677
Teleflex LLC16$588
Boston Scientific7$361
Healthtronics Stone Solutions, LLC7$325
Pfizer13$296
Tolmar Pharmaceuticals, Inc.24$257
Medtronic(2 entities)13$257
Dendreon Pharmaceuticals LLC12$232
Bayer10$186
Novartis7$181
Axonics, Inc.3$168
Calyxo, Inc.1$156
Myovant Sciences Inc.9$148
Procept Biorobotics Corporation3$140
Amgen8$116
Palette Life Sciences, Inc.1$114
Merck7$114
SRS Medical Systems, Inc.1$109
Accord Healthcare, Inc.5$84
Tolmar, Inc.5$82
Urogen Pharma, Inc.3$67
Endo Pharmaceuticals Inc.5$59
Seagen Inc.1$55
Antares Pharma, Inc.3$51
Varian Medical Systems, Inc.1$51
Janssen Scientific Affairs, LLC2$47
180 Medical, Inc.2$45
Myriad Genetic Laboratories, Inc.2$45
AstraZeneca2$44
Progenics Pharmaceuticals, Inc.2$42
Kowa Pharmaceuticals America, Inc.3$40
Ferring Pharmaceuticals Inc.2$32
Siemens Medical Solutions USA, Inc.1$25
E.r. Squibb & Sons, L.L.C.1$20
KARL Storz Endoscopy-america1$20
Sun Pharmaceutical Industries Inc.1$12

How this compares

$20,763 in reported general payments places this provider in the 80th percentile of 79 urology providers in Nebraska.

See all urology providers in Nebraska →

Medicare billing

Part B allowed, 2024
$612,553
Medicare patients
799
Services billed
66,555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Fremont

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →